BALCHEM CORP

BCPC · XNAS

CIK 9326fmd_0NREQSV4FTYWV55MRES3WJZXWPManufacturing · Chemicals & Allied ProductsTemplate: Standard

Coverage: Jan 01, 2009 to Sep 30, 2026, 68 periods

Income Statement · Annual · Millions · USD
Line item	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Total revenues	553	595	644	644	704	799	942	922	954	1,037
Cost of revenue	372	406	439	432	480	556	662	620	617	667
Net interest income	(7)	(8)	(8)	(6)	(4)	(2)	(10)	(23)	–	–
Gross profit	181	189	204	211	224	243	280	302	336	371
Research and development	7	9	12	11	10	14	12	15	17	19
Selling, general and administrative	–	–	–	–	–	–	–	–	–	–
Total operating expenses	90	92	97	109	113	116	135	143	153	161
Operating income	91	97	107	103	111	128	145	159	183	209
Interest expense	7	8	–	–	–	–	–	–	–	–
Interest and investment income	0	0	–	–	–	–	–	–	–	–
Other non-operating income (expense)	(8)	(8)	(8)	(6)	(5)	(2)	(11)	(22)	(16)	(10)
Income before taxes	83	88	99	96	106	125	134	137	166	199
Income tax expense	27	(2)	20	17	22	29	28	29	38	44
Net income from continuing operations	56	90	79	80	85	96	105	109	128	155
Net income	56	90	79	80	85	96	105	109	128	155
Net income to common shareholders	56	90	79	–	–	–	–	–	–	–